Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma

Publisher: Karger

E-ISSN: 2296-4657|3|2|133-141

ISSN: 2296-4681

Source: Ocular Oncology and Pathology, Vol.3, Iss.2, 2016-12, pp. : 133-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract